HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Bergui Selected Research

Indicators and Reagents (Reagents)

4/2007Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Bergui Research Topics

Disease

2Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2002 - 01/2001
1Neoplasms (Cancer)
04/2007
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2007
1Lymphoma (Lymphomas)
08/2000
1Splenic Diseases
08/2000

Drug/Important Bio-Agent (IBA)

1Immunoglobulins (Immunoglobulin)IBA
04/2007
1Indicators and Reagents (Reagents)IBA
04/2007
1Rituximab (Mabthera)FDA Link
08/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
08/2002 - 01/2001